Brief: Kamada Announces Extension Of Collaboration With Massachusetts General Hospital
05/09/2018 12:25
Sept 5 (Reuters) - Kamada Ltd KMDA.TA :
* KAMADA ANNOUNCES EXTENSION OF COLLABORATION WITH
MASSACHUSETTS
GENERAL HOSPITAL FOR A PROOF-OF-CONCEPT STUDY EVALUATING THE
POTENTIAL BENEFIT OF LIQUID ALPHA-1 ANTITRYPSIN ON LIVER
PRESERVATION PRIOR TO TRANSPLANTATION
Source text for Eikon: ID:nGNX6kfkvq
Further company coverage: KMDA.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kamada
See all newsBrief: Kamada Updates On Withholding Tax Procedures On Previously Announced Cash Dividend To Shareholders
Brief: Kamada Announces Planned Transition Of Chief Financial Officer
Brief: Kamada Q2 EPS USD 0.16
Brief: Kamada Announces FDA Approval Of Its New In-House Rabies Virus Neutralization Testing Laboratory
Brief: Kamada Q4 EPS USD 0.06